BUY | SELL | ||
---|---|---|---|
QTY | PRICE | PRICE | QTY |
1 | 1584.20 | 1610.00 | 1 |
5 | 1583.30 | 1611.00 | 15 |
1 | 1582.60 | 1615.00 | 4 |
1 | 1578.80 | 1619.95 | 1 |
1 | 1578.10 | 1665.00 | 108 |
0 | Total | Total | 0 |
BUY | SELL | ||
---|---|---|---|
QTY | PRICE | PRICE | QTY |
1 | 1584.20 | 1610.00 | 1 |
5 | 1583.30 | 1611.00 | 15 |
1 | 1582.60 | 1615.00 | 4 |
1 | 1578.80 | 1619.95 | 1 |
1 | 1578.10 | 1665.00 | 108 |
0 | Total | Total | 0 |
Open | 1,610.00 |
Previous Close | 1,602.60 |
Volume | 1,187.00 |
Value (Lacs) | 19.06 |
VWAP | 0.00 |
Beta | |
Mkt Cap (Rs. Cr.) | 21,876 |
High | 0.00 |
Low | 0.00 |
UC Limit | 1,923.10 |
LC Limit | 1,282.10 |
52 Week High | 1,910.00 |
52 Week Low | 1,097.20 |
Face Value | 1.00 |
All Time High | 1,910.00 |
All Time Low | 321.00 |
20D Avg Volume | 273,978 |
20D Avg Delivery(%) | 26.26 |
Book Value Per Share | 203.47 |
Dividend Yield | 0.46 |
TTM EPS See historical trend | 28.41 (+1.67% YoY) |
TTM PE See historical trend | 56.53 (High PE) |
P/B See historical trend | 7.90 (High P/B) |
Sector PE | 39.88 |
*Delayed by 20 seconds.
Stock Score
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
Days | |
---|---|
5 | - - |
10 | - - |
20 | - - |
50 | - - |
100 | - - |
200 | - - |
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
Days |
---|
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
Days |
---|
1 Week | --% | |
1 Month | --% | |
3 Months | --% | |
YTD | --% | |
1 Year | --% | |
3 Years | --% |
5 out of 9 years Eris Lifesciences has given negative returns in October.
Month | Max. Positive Change(%) | Avg. Positive Change(%) | Max. Negative Change(%) | Avg. Negative Change(%) | Average Change(%) |
---|---|---|---|---|---|
October | 7.95% (2021) | 3.52% | -6.95% (2020) | -4.07% | -0.70% |
Eris Life Consolidated June 2025 Net Sales at Rs 773.00 crore, up 7.4% Y-o-Y Aug 12 2025 01:06 PM
Eris Lifesciences to meet investors in Singapore and Hong Kong Aug 11 2025 05:27 PM
Neutral Eris Lifesciences; target of Rs 1700: Motilal Oswal Aug 08 2025 01:03 PM
Eris Lifesciences eyes Novo Nordisku2019s exit to expand human insulin play in India Aug 07 2025 09:31 PM
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
Qty 2079000 | Price 1350.18 | % Traded 1.55 |
Qty 2000000 | Price 1350 | % Traded 1.49 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
Date | Agenda |
---|
Ex-Date | Type | Dividend (Rs) |
---|
Announcement Date | Ex-Bonus | Ratio |
---|
Ex-Split | Old FV | New FV |
---|
Ex-Right | Ratio | Premium |
---|
Date | Agenda |
---|
Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE(%) | 1 Yr Perform(%) | Net Profit(Rs.) | Net Sales(Rs.) | Debt to Equity |
---|---|---|---|---|---|---|---|---|---|---|
Eris Life | 1,602.60 | 0.39 | 21,829.58 | 56.41 | 7.88 | 12.32 | 19.13 | 374 | 2,893 | 0.85 |
Sun Pharma | 1,688.60 | 0.57 | 405,151.70 | 39.06 | 5.86 | 15.13 | -11.61 | 10,980 | 52,578 | 0.03 |
Divis Labs | 6,604.00 | -0.26 | 175,315.45 | 76.02 | 12.78 | 14.63 | 9.66 | 2,191 | 9,360 | 0.00 |
Cipla | 1,639.10 | 3.90 | 132,400.88 | 24.55 | 4.67 | 16.90 | 5.63 | 5,291 | 27,547 | 0.00 |
Torrent Pharma | 3,570.40 | -0.39 | 120,838.56 | 60.36 | 16.10 | 25.17 | 3.50 | 1,911 | 11,516 | 0.40 |